🎯
LATEST VERIFIED ALGORITHMIC EXECUTION
Quantitative engine captured a net profit of +19.26% on $OC in just 23h 32m.
FDM
$FDMT
🔒 US Equities4D Molecular Therapeutics Inc
AVG HISTORICAL GAP
+1.66%
MAX GAP RECORD
+16.12%
🔒 PRO INSTITUTIONAL
AI PREDICTIVE WIN RATE
94.2%
REVEAL PRO DIRECTION ⚡
SENTINEL HISTORICAL GAP VIEWER
// $FDMT
📊 1-YEAR TIMELINE (GAPS PLOTTED)
🔮 SIMULATE SETUP 🔒
GAP INSPECTION // PLAYBACK PROTOCOL
$FDMT
HISTORICAL GAP OCCURRENCE
Analyzing price jump between T-1 close and opening auction.
EVENT DATE—
GAP MAGNITUDE—
T-1 CLOSE—
OPEN PRICE—
AI DIRECTIONPRO ONLY 🔒
Bullish Opening Gap
Bearish Opening Gap
T-1 Close Baseline
CATALYSTS & GAP HISTORY
| Nov 10, 2026 Earnings Release 2026-11-10 (UNDETERMINED) | 🔮 UPCOMING 🔒 |
| Aug 13, 2026 Earnings Release 2026-08-13 (AFTER CLOSE) |
-0.17%
|
| May 07, 2026 Earnings Release 2026-05-07 (AFTER CLOSE) |
-8.56%
|
| Mar 18, 2026 Earnings Release 2026-03-18 (AFTER CLOSE) |
+16.12%
|
| Nov 10, 2025 Earnings Release 2025-11-10 (BEFORE OPEN) |
-1.43%
|
| Aug 11, 2025 Earnings Release 2025-08-11 (BEFORE OPEN) |
-0.18%
|
| May 07, 2025 Earnings Release 2025-05-07 (AFTER CLOSE) |
+0.16%
|
| Feb 28, 2025 Earnings Release 2025-02-28 (AFTER CLOSE) |
+0.88%
|
VOLATILITY & GAP BIAS
AVG GAP MOVE
3.5%
Bullish Gaps (5)
Bearish Gaps (3)
Neutral / Flat (6)
📖 Intelligence Summary
4DMT operates as a clinical-stage genetic medicines company focused on inventing and developing genetic medicines to treat large market diseases in ophthalmology, pulmonology and cardiology. It develops genetic medicines using its proprietary invention platform, Therapeutic Vector Evolution. It combines the power of the Nobel Prize-winning technology, directed evolution, with approximately…
NEXT UPCOMING PREDICTIVE SIGNAL
STRONG BUY / TARGET +35%
🔓 REVEAL AI SIGNAL & TARGETS ↗